Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer
- 1 June 2004
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 59 (2), 400-405
- https://doi.org/10.1016/j.ijrobp.2003.10.035
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Neoadjuvant Doxil Chemotherapy Prior to Androgen Ablation Plus Radiotherapy for High-Risk Localized Prostate CancerAmerican Journal of Clinical Oncology, 2003
- Magnetic resonance imaging of prostate cancer.Seminars in Urologic Oncology, 2002
- PREDICTING PROSTATE SPECIFIC ANTIGEN OUTCOME PREOPERATIVELY IN THE PROSTATE SPECIFIC ANTIGEN ERAJournal of Urology, 2001
- Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual-echo, steady-state sequencesEuropean Radiology, 2001
- Prostate Cancer Staging: Should MR Imaging Be Used?—A Decision Analytic ApproachRadiology, 2000
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinThe New England Journal of Medicine, 1997
- Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate CancerJAMA, 1997
- Optimization of prostate carcinoma staging: Comparison of imaging and clinical methodsClinical Radiology, 1995
- Re: The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer, by A. W. Partin, J. Yoo, H. B. Carter, J. D. Pearson, D. W. Chan, J. I. Epstein and P. C. Walsh, J. Urol., 150: 110–115, 1993Journal of Urology, 1994